Advertisement
U.S. Markets closed

Xspray Pharma AB (publ) (XSPRAY.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
62.00+1.20 (+1.97%)
At close: 05:29PM CEST
Currency in SEK

Valuation Measures4

Market Cap (intraday) 2.05B
Enterprise Value 1.96B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.07
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -7.01

Trading Information

Stock Price History

Beta (5Y Monthly) 0.92
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 391.70
52 Week Low 330.90
50-Day Moving Average 350.24
200-Day Moving Average 352.15

Share Statistics

Avg Vol (3 month) 356.09k
Avg Vol (10 day) 324.11k
Shares Outstanding 533.76M
Implied Shares Outstanding 6N/A
Float 822.29M
% Held by Insiders 131.36%
% Held by Institutions 142.73%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-5,785.91%

Management Effectiveness

Return on Assets (ttm)-20.76%
Return on Equity (ttm)-37.74%

Income Statement

Revenue (ttm)-196k
Revenue Per Share (ttm)-0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -208.42M
Net Income Avi to Common (ttm)-214.76M
Diluted EPS (ttm)-6.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)126.57M
Total Cash Per Share (mrq)3.75
Total Debt (mrq)34.84M
Total Debt/Equity (mrq)5.21
Current Ratio (mrq)4.67
Book Value Per Share (mrq)19.79

Cash Flow Statement

Operating Cash Flow (ttm)-220.73M
Levered Free Cash Flow (ttm)-221.57M